Last ¥7,340 JPY
Change Today 0.00 / 0.00%
Volume 1.3K
8686 On Other Exchanges
New York
As of 12:57 AM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

aflac inc (8686) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/24/14 - ¥7,480
52 Week Low
10/16/14 - ¥5,930
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for AFLAC INC (8686)

aflac inc (8686) Details

Aflac Incorporated, through its subsidiary, American Family Life Assurance Company of Columbus, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The company offers various voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan. It also provides products designed to protect individuals from depletion of assets, which comprise accident, cancer, critical illness/critical care, hospital intensive care, hospital indemnity, fixed-benefit dental, and vision care plans; and loss-of-income products, such as life and short-term disability plans in the United States. The company sells its products through sales associates and brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

Founded in 1955

aflac inc (8686) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $1.4M
President, Chief Financial Officer, Treasurer...
Total Annual Compensation: $951.6K
Director, Member of Executive Committee, Memb...
Total Annual Compensation: $633.0K
Vice Chairman of Aflac Japan
Total Annual Compensation: $764.2K
Global Chief Investment Officer and Executive...
Total Annual Compensation: $566.5K
Compensation as of Fiscal Year 2013.

aflac inc (8686) Key Developments

Aflac Incorporated Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

Aflac Incorporated reported earnings results for the fourth quarter and full year ended December 31, 2014. The company reported the annualized return on shareholders' equity was revised from 16.3% to 16.5% for the fourth quarter and from 18.9% to 19.1%, excluding the impact of the yen. For the full year, operating return on average shareholders' equity, excluding currency, was revised from 22.6% to 22.9%.

Aflac Incorporated Launches New Critical Illness Plan

Aflac Incorporated has launched Critical Care Protection, a new critical illness plan which offers a range of coverage options as well as new benefits for heart conditions. In the event of a heart attack or stroke, the Critical Care Protection plan is designed to help provide policyholders with a financial safety net so they can concentrate on their recovery and not on money matters. There are three plan options featuring enhanced benefits coverage, such as: first-occurrence benefit, subsequent health event benefit, and coronary angioplasty benefit. Under first-occurrence benefit, cash benefit is increased to $7,500 payable once per covered person, per lifetime and $10,000 for dependent children. Under subsequent health event benefit, cash benefit is increased to $3,500 payable per covered person, and under coronary angioplasty benefit, cash benefit is increased to $1,000 payable once per covered person, per lifetime. In addition, plan Option 3 includes all benefits in Options 1 and 2 as well as these new benefits which include: specified heart surgery benefits, subsequent specified heart surgery benefit, and specified heart surgery benefits. Under specified heart surgery benefits, cash benefit of $4,000 for heart valve surgery and surgical treatment of abdominal aortic aneurysm per covered person is provided. Under subsequent specified heart surgery benefit, cash benefit of $1,000 payable per covered person, per lifetime is provided, and under specified heart surgery benefits, cash benefit of $2,000 per covered person, per lifetime, such as, coronary angioplasty, coronary stent implantation, cardiac catheterization, and pacemaker placement is provided. Critical illness supplemental coverage helps provide protection from the financial liability that can accompany certain health events. Aflac's Critical Care Protection voluntary insurance policy works side-by-side with major medical plans by offering cash benefits that can be used to pay deductibles, copayments and household expenses, such as rent or mortgage, utilities, child care and credit card debt. Ensuring policyholders get their benefits paid quickly, the insurer recently launched One Day Pay for eligible claims submitted online through the Aflac SmartClaim- system.

AFLAC Inc., Board Meeting, Feb 10, 2015

AFLAC Inc., Board Meeting, Feb 10, 2015. Agenda: To consider the appointment of Thomas J. Kenny to its Board of Directors.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8686:JP ¥7,340.00 JPY 0.00

8686 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ameriprise Financial Inc $133.63 USD -1.71
Marsh & McLennan Cos Inc $56.89 USD -0.12
Sun Life Financial Inc C$38.50 CAD +0.25
Chubb Corp/The $100.45 USD -0.21
Travelers Cos Inc/The $107.44 USD -0.38
View Industry Companies

Industry Analysis


Industry Average

Valuation 8686 Industry Range
Price/Earnings 9.5x
Price/Sales 1.2x
Price/Book 1.5x
Price/Cash Flow 9.3x
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AFLAC INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at